In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 16, 2012, Pages 6223-6228

  Martínez Corral, Inés ^a,c   Olmeda, David ^a   Diéguez Hurtado, Rodrigo ^a   Tammela, Tuomas ^b   Alitalo, Kari ^b   Ortega, Sagrario ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSITY OF HELSINKI   (Finland)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Bioluminescence; Fluorescence; Knockin mouse

Indexed keywords

DEXAMETHASONE; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; DOWN REGULATION; EMBRYO DEVELOPMENT; FEMALE; IN VIVO STUDY; INFLAMMATION; LUMINESCENCE; LYMPHANGIOGENESIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

ANIMALS; CELL LINE, TUMOR; DEXAMETHASONE; DIAGNOSTIC IMAGING; EMBRYO, MAMMALIAN; FEMALE; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; INFLAMMATION; LUCIFERASES; LUMINESCENT MEASUREMENTS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; NEOPLASMS, EXPERIMENTAL; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; WOUND HEALING;

EID: 84860008988     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1115542109     Document Type: Article

References (54)

1. Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 3:367-397. (Pubitemid 351488286)
2. Baluk P, et al. (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115:247-257. (Pubitemid 40385467)
3. Kataru RP, et al. (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113:5650-5659.
4. Kerjaschki D (2005) The crucial role of macrophages in lymphangiogenesis. J Clin Invest 115:2316-2319.
5. Skobe M, et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198. (Pubitemid 32148486)
6. Stacker SA, et al. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191. (Pubitemid 32148485)
7. Karpanen T, et al. (2001) Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61:1786-1790. (Pubitemid 32691984)
8. Wong SY, et al. (2005) Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 65:9789-9798. (Pubitemid 41541456)
9. Sipos B, et al. (2005) Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J Pathol 207:301-312. (Pubitemid 41556454)
10. Padera TP, et al. (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296:1883-1886. (Pubitemid 34596277)
11. Sugiura T, et al. (2009) VEGF-C and VEGF-D expression is correlated with lymphatic vessel density and lymph node metastasis in oral squamous cell carcinoma: Implications for use as a prognostic marker. Int J Oncol 34:673-680.
12. Williams CS, et al. (2003) Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 200:195-206. (Pubitemid 36748028)
13. Dadras SS, et al. (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18:1232-1242. (Pubitemid 43079923)
14. Hirakawa S, et al. (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109:1010-1017. (Pubitemid 46220646)
15. Tobler NE, Detmar M (2006) Tumor and lymph node lymphangiogenesis - impact on cancer metastasis. J Leukoc Biol 80:691-696. (Pubitemid 44835883)
16. Choi I, et al. (2011) Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse. Blood 117: 362-365.
17. Hägerling R, Pollmann C, Kremer L, Andresen V, Kiefer F (2011) Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse. Biochem Soc Trans 39:1674-1681.
18. Truman LA, et al. (2012) ProxTom lymphatic vessel reporter mice reveal Prox1 expression in the adrenal medulla, megakaryocytes, and platelets. Am J Pathol, 10.1016/ j.ajpath.2011.12.026.
19. Mumprecht V, et al. (2010) In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. Cancer Res 70:8842-8851.
20. Tammela T, Alitalo K (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140:460-476.
21. Tammela T, et al. (2011) VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol 13:1202-1213.
22. Tammela T, et al. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454:656-660.
23. Petrova TV, et al. (2008) VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors. Cancer Cell 13:554-556. (Pubitemid 351763905)
24. Partanen TA, et al. (2000) VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14: 2087-2096.
25. Schoppmann SF, et al. (2002) Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 161:947-956. (Pubitemid 34988382)
26. Le Bras B, et al. (2006) VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain. Nat Neurosci 9:340-348. (Pubitemid 43290963)
27. Orlandini M, et al. (2006) Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation. J Biol Chem 281:17961-17967. (Pubitemid 44035595)
28. Dumont DJ, et al. (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-949. (Pubitemid 28507528)
29. Kaipainen A, et al. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570.
30. Enholm B, et al. (2001) Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res 88:623-629. (Pubitemid 32275799)
31. Karpanen T, et al. (2006) Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 169:708-718. (Pubitemid 44156326)
32. Louzier V, et al. (2003) Role of VEGF-B in the lung during development of chronic hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 284:L926-L937. (Pubitemid 36687127)
33. Wirzenius M, et al. (2007) Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 204:1431-1440. (Pubitemid 46919880)
34. Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154-165.
35. Martin P (1997) Wound healing - aiming for perfect skin regeneration. Science 276: 75-81.
36. Maruyama K, et al. (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170:1178-1191. (Pubitemid 47339326)
37. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156: 1499-1504. (Pubitemid 30646689)
38. Saaristo A, et al. (2004) Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J 18:1707-1709. (Pubitemid 39561658)
39. Hos D, et al. (2011) Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol 129:445-452.
40. Yano A, et al. (2006) Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells. Clin Cancer Res 12:6012-6017. (Pubitemid 44703762)
41. Yao LC, Baluk P, Feng J, McDonald DM (2010) Steroid-resistant lymphatic remodeling in chronically inflamed mouse airways. Am J Pathol 176:1525-1541.
42. Greco KV, Lara PF, Oliveira-Filho RM, Greco RV, Sudo-Hayashi LS (2006) Lymphatic regeneration across an incisional wound: Inhibition by dexamethasone and aspirin, and acceleration by a micronized purified flavonoid fraction. Eur J Pharmacol 551: 131-142. (Pubitemid 44648056)
43. Billiau A, Matthys P (2001) Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J Leukoc Biol 70:849-860. (Pubitemid 33151123)
44. Mancardi S, et al. (1999) Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant. Exp Cell Res 246:368-375. (Pubitemid 29393999)
45. Quintanilla M, Brown K, Ramsden M, Balmain A (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78-80. (Pubitemid 16061512)
46. Achen MG, McColl BK, Stacker SA (2005) Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7:121-127. (Pubitemid 40248338)
47. Rinderknecht M, Detmar M (2008) Tumor lymphangiogenesis and melanoma metastasis. J Cell Physiol 216:347-354. (Pubitemid 351898461)
48. Dadras SS, et al. (2003) Tumor lymphangiogenesis: A novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951-1960. (Pubitemid 36613052)
49. Skobe M, et al. (2001) Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 159:893-903. (Pubitemid 32847180)
50. Supino R, Prosperi E, Formelli F, Mariani M, Parmiani G (1986) Characterization of a doxorubicin-resistant murine melanoma line: Studies on cross-resistance and its circumvention. Br J Cancer 54:33-42. (Pubitemid 16093182)
51. Zhang N, Fang Z, Contag PR, Purchio AF, West DB (2004) Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse. Blood 103:617-626. (Pubitemid 38140096)
52. Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: Seeing fundamental biological processes in a new light. Genes Dev 17:545-580. (Pubitemid 36307540)
53. Mumprecht V, Detmar M (2009) Lymphangiogenesis and cancer metastasis. J Cell Mol Med 13(8A):1405-1416.
54. Harrell MI, Iritani BM, Ruddell A (2007) Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170:774-786. (Pubitemid 47339411)